SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Celera Genomics (CRA)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: gao seng who wrote (291)5/8/2000 2:49:00 AM
From: GlobalMarine  Read Replies (2) of 746
 
Gao Seng: Thanks for the article. I don't know how you feel about things, but I rather feel Celera should simply do what the other public genomics companies are doing and not bother releasing its database. Instead, Celera should just go full steam ahead identifying therapeutic genes and patenting same. THAT is where the big money is down the road, partnering with a gene delivery co. like TGEN or AVGN to produce gene therapy drugs. I don't think the company is going to make a killing on on subscriptions, esp. after the HGP will provide cheap access to its database. I have to believe Venter is smart enough to realize that the other competing genomics companies are patenting therapeutic genes and not wasting time thinking about subscriptions.

Of course, Celera has put itself on the front pages of newspapers and if it decided to keep the database to itself, they'd be some political fallout. But since the HGP is going to release everything anyway, I say damn the torpedoes, full speed ahead.

Global
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News